CRISPR Therapeutics AG ($CRSP)
Filing Information
| Accession Number | 0001193125-26-111284 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 17, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
44,369
Total Value
$476,277.94
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Shares | โ | Mar 14, 2026 | Exercise/Conversion | 10,000 | โ | โ | 16,767 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Mar 14, 2026 | Exercise/Conversion | 6,875 | โ | โ | 23,642 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Mar 16, 2026 | Sale | 5,848 | $48.26 | $282,224.48 | 17,794 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Mar 16, 2026 | Sale | 4,021 | $48.26 | $194,053.46 | 13,773 | Direct | โ | View Details | |
Chief Financial Officer | Common Shares | โ | Mar 16, 2026 | Gift | 750 | $0.00 | $0.00 | 13,023 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Mar 14, 2026 | Exercise/Conversion | 10,000 | โ | โ | 10,000 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Mar 14, 2026 | Exercise/Conversion | 6,875 | โ | โ | 20,625 | Direct | โ | View Details |